ArticleInternational ophthalmology2025
Impact of external dacryocystorhinostomy on corneal aberrations and optical quality in primary acquired nasolacrimal duct obstruction.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the impact of external dacryocystorhinostomy (EXT-DCR) on optical quality in patients with primary acquired nasolacrimal duct obstruction (PANDO) by evaluating changes in corneal higher-order aberrations (HOAs) and key optical quality parameters, including modulation transfer function (MTF) and point spread function (PSF).
methodsThis retrospective study included 26 eyes of 26 patients who underwent unilateral EXT-DCR for PANDO. Preoperative and 6-month postoperative assessments included best-corrected visual acuity (BCVA), manifest refraction spherical equivalent (MRSE), and epiphora severity (Munk score, fluorescein dye disappearance test [FDDT]). HOAs, MTF, and PSF were analyzed at 3 mm and 6 mm pupil diameters using Sirius corneal topography. Paired t-tests, Wilcoxon signed-rank tests, and Spearman correlation analyses were used.
resultsPostoperatively, HOA significantly decreased at 3 mm (0.183 ± 0.160 - 0.128 ± 0.058 µm, p = 0.020) and 6 mm (0.744 ± 0.350 - 0.641 ± 0.271 µm, p = 0.039). Spherical aberration at 6 mm also significantly decreased (- 0.237 ± 0.203 - - 0.194 ± 0.247 µm, p = 0.032). MTF and PSF values showed no significant postoperative changes (p > 0.05). Correlation analysis of Δ values (preoperative-postoperative changes) revealed significant associations between reductions in Munk/FDDT scores and improvements in HOA and spherical aberrations (p < 0.05).
conclusionEXT-DCR may significantly improve optical quality by reducing HOAs and spherical aberrations. The correlation between epiphora resolution and optical quality suggests that stabilizing the tear film plays a key role in reducing optical distortions. While MTF and PSF values did not show significant changes, further studies with larger cohorts and advanced imaging techniques are warranted to explore the broader impact of lacrimal surgery on visual function and contrast sensitivity parameters.
Indexed as
Identifiers
40888986What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.